COVID-19-Associated Cancer Screening Deficit Quantified in U.S.
Absolute deficit in screening estimated at 3.9, 3.8, and 1.6 million for breast, colorectal, and prostate cancers, respectively
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.